FDA OKs First New Treatment for Sickle Cell in Almost 20 Years FDA OKs First New Treatment for Sickle Cell in Almost 20 Years

The FDA has approved L-glutamine oral powder (Endari, Emmaus Medical Inc) for patients aged 5 years and older with sickle cell disease.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news